Related references
Note: Only part of the references are listed.Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein of the testis carcinoma and other cancers: Results of a Phase I/II open-label, dose escalation study
Sophie Cousin et al.
INTERNATIONAL JOURNAL OF CANCER (2022)
Introduction to 2021 WHO Classification of Thoracic Tumors
Ming-Sound Tsao et al.
JOURNAL OF THORACIC ONCOLOGY (2022)
A Phase 1 study of RO6870810, a novel bromodomain and extra-terminal protein inhibitor, in patients with NUT carcinoma, other solid tumours, or diffuse large B-cell lymphoma
Geoffrey I. Shapiro et al.
BRITISH JOURNAL OF CANCER (2021)
Genomic profiling of solid tumors harboring BRD4-NUT and response to immune checkpoint inhibitors
Jonathan W. Riess et al.
TRANSLATIONAL ONCOLOGY (2021)
Immunotherapy and Targeting the Tumor Microenvironment: Current Place and New Insights in Primary Pulmonary NUT Carcinoma
Xiang Li et al.
FRONTIERS IN ONCOLOGY (2021)
Incidence of NUT carcinoma in Western Australia from 1989 to 2014: a review of pediatric and adolescent cases from Perth Children's Hospital
Tina Carter et al.
BMC CANCER (2021)
NUTM1-Rearranged Neoplasms-A Heterogeneous Group of Primitive Tumors with Expanding Spectrum of Histology and Molecular Alterations-An Updated Review
Wenyi Luo et al.
CURRENT ONCOLOGY (2021)
Emerging entities in NUTM1-rearranged neoplasms
Christopher R. McEvoy et al.
GENES CHROMOSOMES & CANCER (2020)
Nuclear protein in testis (NUT) midline carcinoma
Karolin Baumgartner et al.
ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN (2020)
Clinical features, treatment, and survival outcome of primary pulmonary NUT midline carcinoma
Xiao-Hong Xie et al.
ORPHANET JOURNAL OF RARE DISEASES (2020)
An Anatomical Site and Genetic-Based Prognostic Model for Patients With Nuclear Protein in Testis (NUT) Midline Carcinoma: Analysis of 124 Patients
Nicole G. Chau et al.
JNCI CANCER SPECTRUM (2020)
Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors
Sarina A. Piha-Paul et al.
JNCI CANCER SPECTRUM (2020)
NUT carcinoma in a nutshell: A diagnosis to be considered more frequently
Thomas Albrecht et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
NUT midline carcinoma of the head and neck: current perspectives
M. Napolitano et al.
ONCOTARGETS AND THERAPY (2019)
Pediatric NUT Carcinoma Is a Rare and Challenging Tumor: Single Center Experience of Five Children
Maya Prasad et al.
ONCOLOGIST (2019)
NUT midline carcinoma: Current concepts and future perspectives of a novel tumour entity
Massimiliano Salati et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
Patterns of care and impact of prognostic factors in the outcome of NUT midline carcinoma: a systematic review and individual patient data analysis of 119 cases
Prashanth Giridhar et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2018)
Phase Ib Trial With Birabresib, a Small-Molecule Inhibitor of Bromodomain and Extraterminal Proteins, in Patients With Selected Advanced Solid Tumors
Jeremy Lewin et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
The novel BET bromodomain inhibitor BI 894999 represses super-enhancer-associated transcription and synergizes with CDK9 inhibition in AML
Daniel Gerlach et al.
ONCOGENE (2018)
Sinonasal Nuclear Protein Testis Midline Carcinoma: Case Report with a Review of the Literature
Megan Le et al.
Journal of Neurological Surgery Part B-Skull Base (2018)
NUT Carcinoma: Clinicopathologic features, pathogenesis, and treatment
Christopher A. French
PATHOLOGY INTERNATIONAL (2018)
Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
Loren M. Lasko et al.
NATURE (2017)
Pediatric NUT-midline carcinoma: Therapeutic success employing a sarcoma based multimodal approach
Simone Storck et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2017)
Ectopic protein interactions within BRD4-chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma
Artyom A. Alekseyenko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma
J-K. Lee et al.
ANNALS OF ONCOLOGY (2017)
Intensive Treatment and Survival Outcomes in NUT Midline Carcinoma of the Head and Neck
Nicole G. Chau et al.
CANCER (2016)
Cytopathologic Features of NUT Midline Carcinoma: A Series of 26 Specimens From 13 Patients
Justin A. Bishop et al.
CANCER CYTOPATHOLOGY (2016)
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains
Artyom A. Alekseyenko et al.
GENES & DEVELOPMENT (2015)
Histone Deacetylase Inhibitor for NUT Midline Carcinoma
Ossama M. Maher et al.
PEDIATRIC BLOOD & CANCER (2015)
Demystifying NUT Midline Carcinoma: Radiologic and Pathologic Correlations of an Aggressive Malignancy
Ryan J. Bair et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2014)
NSD3-NUT Fusion Oncoprotein in NUT Midline Carcinoma: Implications for a Novel Oncogenic Mechanism
Christopher A. French et al.
CANCER DISCOVERY (2014)
NUT Midline Carcinoma: A Case Report with a Novel Translocation and Review of the Literature
Andrew F. Mills et al.
HEAD & NECK PATHOLOGY (2014)
The Importance of Diagnosing NUT Midline Carcinoma
C. A. French
HEAD & NECK PATHOLOGY (2013)
Clinicopathologic Features and Long-term Outcomes of NUT Midline Carcinoma
Daniel E. Bauer et al.
CLINICAL CANCER RESEARCH (2012)
Radiologic features of NUT midline carcinoma in an adolescent
Daniel G. Rosenbaum et al.
PEDIATRIC RADIOLOGY (2012)
Differentiation of NUT Midline Carcinoma by Epigenomic Reprogramming
Brian E. Schwartz et al.
CANCER RESEARCH (2011)
Cytology of Head and Neck Squamous Cell Carcinoma Variants
Deborah J. Chute et al.
DIAGNOSTIC CYTOPATHOLOGY (2010)
Demystified molecular pathology of NUT midline carcinomas
Christopher A. French
JOURNAL OF CLINICAL PATHOLOGY (2010)
Long-Term Survival of a Patient with Squamous Cell Carcinoma Harboring NUT Gene Rearrangement
Naomi Fujioka et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Selective inhibition of BET bromodomains
Panagis Filippakopoulos et al.
NATURE (2010)
NUT Mid line Carcinoma in a Newborn with Multiorgan Disseminated Tumor and a 2-Year-Old with a Pancreatic/Hepatic Primary
Bahig M. Shehata et al.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2010)
Diagnosis of NUT Midline Carcinoma Using a NUT-specific Monoclonal Antibody
Herbert Haack et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2009)
BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells
C. A. French et al.
ONCOGENE (2008)
Successful treatment of a child with t(15;19)-positive tumor
Fredrik Mertens et al.
PEDIATRIC BLOOD & CANCER (2007)
Midline carcinoma of children and young adults with NUT rearrangement
CA French et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis
A Dey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Share Paper
